Mangoceuticals Cash Flow Statement (2023-2026) | MGRX

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -2.56M-2.28M-1.80M-2.57M-2.37M-2.39M-2.00M-1.95M-4.84M-5.42M-7.62M-2.77M-3.40M
Depreciation and Depletion (Quarter) 0.01M0.01M0.01M0.01M0.01M0.00M252.00255.00250.00252.00255.00255.00250.00
Share-based Compensation (Quarter) 0.70M0.06M0.07M0.43M0.04M0.05M1.59M-1.43M1.94M3.18M-3.91M9.51M0.59M
Cash from Operations (Quarter) -1.81M-1.78M-1.71M-1.70M-0.99M-1.58M-1.17M-1.13M-2.27M-1.26M-1.24M-1.08M-1.31M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter) 0.01M0.01M0.01M0.01M0.01M0.00M255.00250.00252.00256.00255.00250.00
Change in Working Capital
Change in Inventory (Quarter) -0.00M-0.00M-0.00M-433.00-806.00
Change in Account Payables (Quarter) -0.11M
Change in Accured Expenses (Quarter) -0.01M0.11M-0.04M0.05M0.88M-0.30M-0.60M0.72M0.34M0.09M-0.64M0.27M-0.01M
Change in Taxes (Quarter) 0.00M-0.00M0.00M-0.00M893.00-0.01M0.00M0.00M-0.01M
Investing Activities
Capital Expenditures (Quarter) 0.00M
Cash from Investing Activities (Quarter) -0.00M
Financing Activities
Other financing activities (Quarter) 0.48M0.15M0.30M
Cash from Financing Activities (Quarter) 5.00M0.86M1.20M0.27M1.99M0.75M1.12M2.29M1.28M1.62M2.08M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter) 5.00M0.65M1.20M0.18M0.39M0.76M0.66M0.43M1.32M2.21M
Additional items
Exchange Rate Effect (Quarter) -70.00-0.00M-497.00-0.01M0.01M187.00-45.00-681.00-433.00
Change in Cash (Quarter) 3.19M-0.92M-1.71M-0.50M-0.72M0.48M-0.42M-0.01M0.01M0.02M0.38M1.01M-1.31M
Free Cash Flow (Quarter) -1.81M-1.78M-1.71M-1.70M-0.99M-1.58M-1.17M-1.13M-2.27M-1.26M-1.24M-1.08M-1.31M
Net Cash Flow (Quarter) 3.19M-0.92M-1.71M-0.50M-0.72M0.41M-0.42M-0.01M0.01M0.02M0.38M1.01M-1.31M